Harvard University
Cambridge, Massachusetts, United States
Purpose
to evaluate different COVID vaccine platforms in the lymphoid follicle system in order to better understand how this in vitro system might be used to inform future selections of vaccine platforms for other vaccine antigens
Division
Global Health
Date
August 2022
Region Served
GLOBAL
Committed amount
$852,419
Grant topic
Discovery and Translational Sciences
Duration (months)
22
Grantee location
Cambridge, Massachusetts, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.